HONYAKU Center Inc. Logo

HONYAKU Center Inc.

Provides industrial translation and interpreting for patent, legal, and corporate clients.

2483 | T

Overview

Corporate Details

ISIN(s):
JP3854900002
LEI:
Country:
Japan
Address:
大阪市中央区久太郎町4丁目1番3号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HONYAKU Center Inc. is a leading provider of industrial and technical translation services. Established in 1986 as a medical translation specialist, the company has expanded to offer comprehensive language solutions across diverse sectors, including patent, pharmaceutical, legal, financial, automotive, and electronics. Its core services include the translation of specialized documents like application statements and priority certificates. In addition to translation, the company provides related services such as interpreter dispatching for meetings and business negotiations. As one of Japan's largest industrial translation firms, HONYAKU Center supports a broad range of clients, from patent offices to global corporations, by leveraging experienced professional translators and advanced translation support tools to meet the demands of global business.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 02:01
Registration Form
確認書
Japanese 8.4 KB
2025-11-13 02:00
Interim Report
半期報告書-第40期(2025/04/01-2026/03/31)
Japanese 185.3 KB
2025-06-30 02:13
Post-Annual General Meeting Information
臨時報告書
Japanese 26.2 KB
2025-06-25 06:08
Governance Information
内部統制報告書-第39期(2024/04/01-2025/03/31)
Japanese 23.9 KB
2025-06-25 06:07
Registration Form
確認書
Japanese 8.3 KB
2025-06-25 06:06
Annual Report
有価証券報告書-第39期(2024/04/01-2025/03/31)
Japanese 812.7 KB
2024-11-13 01:28
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-11-13 01:27
Interim Report
半期報告書-第39期(2024/04/01-2025/03/31)
Japanese 188.1 KB
2024-06-28 02:06
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2024-06-27 02:14
Governance Information
内部統制報告書-第38期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-27 02:13
Registration Form
確認書
Japanese 8.3 KB
2024-06-27 02:12
Annual Report
有価証券報告書-第38期(2023/04/01-2024/03/31)
Japanese 795.6 KB
2024-02-13 02:46
Registration Form
確認書
Japanese 8.3 KB
2024-02-13 02:44
Quarterly Report
四半期報告書-第38期第3四半期(2023/10/01-2023/12/31)
Japanese 154.7 KB
2023-11-14 01:49
Regulatory News Service
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all HONYAKU Center Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HONYAKU Center Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HONYAKU Center Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.